XtalPi (HKEX: 2228.HK) hosted a high-level delegation from the Massachusetts Institute of Technology (MIT), including Prof. Troy Van Voorhis, Head of the Department of Chemistry, and Corrie Lefebvre, Director of Commercialization Partnerships. The visit marked a significant step toward advancing AI for Science, with discussions focused on reshaping the future of chemistry and materials research through AI and robotics.

A Meeting of Minds
The delegation, joined by Prof. Haitao Zhao of The Hong Kong Polytechnic University, explored XtalPi’s state-of-the-art AI-driven automated laboratories. Dr. Peiyu Zhang, XtalPi’s Chief Scientific Officer, showcased the company’s advancements in reaction prediction and design. Prof. Zhao presented collaborative successes in AI-powered materials innovation, demonstrating the platform’s ability to deliver novel structures, formulations, and processes beyond traditional scientific expectations.

Revolutionizing Research with AI + Robotics
XtalPi’s intelligent materials R&D platform integrates automated synthesis and in-situ characterization, enabling rapid discovery and validation of new materials. Recent achievements in perovskite development have demonstrated unprecedented speed and potential, earning praise from MIT’s delegation.
“What XtalPi has achieved with AI and robotics is truly remarkable,” said Prof. Van Voorhis, a leading expert in solar cell electron dynamics. “Their ability to integrate vast datasets and leverage robotic systems for efficient data collection opens new possibilities for scientific discovery.”
Driving Efficiency in R&D
Traditional drug and materials development often faces lengthy timelines and high failure rates. XtalPi’s platform addresses these challenges by executing tens of thousands of chemical reactions monthly with hundreds of precision robotic systems, leveraging negative sample learning to improve failure prediction accuracy, reducing R&D risks, and achieved a 90% prediction success rate in 10 recent projects, earning widespread recognition from pharmaceutical and materials science clients.
A Shared Vision for the Future
The visit underscored the alignment between MIT and XtalPi in harnessing AI to push the boundaries of scientific research. Both parties expressed strong interest in deepening collaboration to explore new frontiers in automation and AI, with the potential to deliver transformative breakthroughs.